KR102307424B1 - 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정 - Google Patents

혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정 Download PDF

Info

Publication number
KR102307424B1
KR102307424B1 KR1020207019527A KR20207019527A KR102307424B1 KR 102307424 B1 KR102307424 B1 KR 102307424B1 KR 1020207019527 A KR1020207019527 A KR 1020207019527A KR 20207019527 A KR20207019527 A KR 20207019527A KR 102307424 B1 KR102307424 B1 KR 102307424B1
Authority
KR
South Korea
Prior art keywords
methylation
delete delete
cancer
plasma
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207019527A
Other languages
English (en)
Korean (ko)
Other versions
KR20200085928A (ko
Inventor
로사 와이 퀀 치우
콴 치 찬
유크 밍 데니스 로
미우 판 룬
페이용 지앙
와이 만 찬
Original Assignee
더 차이니즈 유니버시티 오브 홍콩
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102307424(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by 더 차이니즈 유니버시티 오브 홍콩 filed Critical 더 차이니즈 유니버시티 오브 홍콩
Priority to KR1020217030373A priority Critical patent/KR102390711B1/ko
Publication of KR20200085928A publication Critical patent/KR20200085928A/ko
Application granted granted Critical
Publication of KR102307424B1 publication Critical patent/KR102307424B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
KR1020207019527A 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정 Active KR102307424B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217030373A KR102390711B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US61/703,512 2012-09-20
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US13/842,209 2013-03-15
US201361830571P 2013-06-03 2013-06-03
US61/830,571 2013-06-03
PCT/AU2013/001088 WO2014043763A1 (en) 2012-09-20 2013-09-20 Non-invasive determination of methylome of fetus or tumor from plasma
KR1020157010184A KR102148547B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020157010184A Division KR102148547B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217030373A Division KR102390711B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Publications (2)

Publication Number Publication Date
KR20200085928A KR20200085928A (ko) 2020-07-15
KR102307424B1 true KR102307424B1 (ko) 2021-09-29

Family

ID=50340462

Family Applications (5)

Application Number Title Priority Date Filing Date
KR1020227013227A Active KR102587176B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020237033920A Ceased KR20230145530A (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020217030373A Active KR102390711B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020157010184A Active KR102148547B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020207019527A Active KR102307424B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Family Applications Before (4)

Application Number Title Priority Date Filing Date
KR1020227013227A Active KR102587176B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020237033920A Ceased KR20230145530A (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020217030373A Active KR102390711B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정
KR1020157010184A Active KR102148547B1 (ko) 2012-09-20 2013-09-20 혈장으로부터 태아 또는 종양 메틸롬의 비침습적 결정

Country Status (28)

Country Link
EP (6) EP3839065A1 (enExample)
JP (6) JP6317354B2 (enExample)
KR (5) KR102587176B1 (enExample)
CN (2) CN104781422B (enExample)
AU (5) AU2013317708C1 (enExample)
BR (3) BR112015006183B1 (enExample)
CA (2) CA2884066C (enExample)
CY (1) CY1124139T1 (enExample)
DK (4) DK3536807T3 (enExample)
EA (1) EA201500327A1 (enExample)
ES (4) ES2994426T3 (enExample)
FI (2) FI4056712T3 (enExample)
HR (3) HRP20240210T1 (enExample)
HU (3) HUE068129T2 (enExample)
IL (4) IL299444B2 (enExample)
LT (2) LT3354747T (enExample)
MX (1) MX360034B (enExample)
MY (2) MY173356A (enExample)
NZ (2) NZ717423A (enExample)
PH (2) PH12015500547B1 (enExample)
PL (4) PL2898100T5 (enExample)
PT (4) PT3536807T (enExample)
SG (2) SG10201705198UA (enExample)
SI (1) SI4056712T1 (enExample)
SM (1) SMT202100256T1 (enExample)
TW (4) TWI806621B (enExample)
WO (1) WO2014043763A1 (enExample)
ZA (1) ZA201501772B (enExample)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI335354B (en) 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
WO2014043763A1 (en) * 2012-09-20 2014-03-27 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2685893T3 (es) * 2013-07-30 2018-10-15 Bgi Genomics Co., Limited Método para determinar la composición de ácidos nucleicos de una mezcla de ácidos nucleicos
US10174375B2 (en) 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
US12054771B2 (en) * 2014-02-18 2024-08-06 Bionano Genomics, Inc. Methods of determining nucleic acid structural information
AU2015249846B2 (en) * 2014-04-21 2021-07-22 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
EP3521454A1 (en) 2014-05-09 2019-08-07 LifeCodexx AG Detection of dna that originates from a specific cell-type and related methods
WO2016010401A1 (ko) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법
TWI727156B (zh) * 2014-07-18 2021-05-11 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
WO2016015058A2 (en) 2014-07-25 2016-01-28 University Of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
ES3017068T3 (en) * 2014-12-31 2025-05-12 Guardant Health Inc Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US10364467B2 (en) 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
SG11201706529TA (en) 2015-02-10 2017-09-28 Univ Hong Kong Chinese Detecting mutations for cancer screening and fetal analysis
EP3325663B1 (en) 2015-07-20 2020-08-19 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in dna mixture
DK3325664T3 (da) 2015-07-23 2022-03-07 Univ Hong Kong Chinese Analyse af fragmenteringsmønstre for cellefrit DNA
TWI793586B (zh) 2015-08-12 2023-02-21 香港中文大學 血漿dna之單分子定序
TWI858334B (zh) 2015-09-22 2024-10-11 香港中文大學 藉由母體血漿ｄｎａ之淺深度測序以準確定量胎兒dna含量
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
EP4180532A1 (en) * 2015-11-09 2023-05-17 Roche Molecular Systems, Inc. Methods for determining the origin of dna molecules
HUE050491T2 (hu) 2015-11-10 2020-12-28 Eurofins Lifecodexx Gmbh Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között
US11319593B2 (en) 2015-12-17 2022-05-03 Illumina, Inc. Distinguishing methylation levels in complex biological samples
SG11201806609TA (en) * 2016-02-02 2018-09-27 Guardant Health Inc Cancer evolution detection and diagnostic
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
EP4425178A3 (en) * 2016-05-03 2024-12-18 University Health Network Methods of capturing cell-free methylated dna and uses of same
US12300356B2 (en) 2016-05-04 2025-05-13 Queen's University At Kingston Cell-free detection of methylated tumour DNA
IL262953B2 (en) 2016-05-30 2023-11-01 Univ Hong Kong Chinese Detection of hematological disorders using cell-free DNA in blood
AU2017285496B2 (en) * 2016-06-16 2023-02-23 The Johns Hopkins University Methods and system for epigenetic analysis
CN107779485B (zh) 2016-08-24 2022-03-18 中国科学院分子细胞科学卓越创新中心 Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用
WO2018072705A1 (en) * 2016-10-19 2018-04-26 The Chinese University Of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma dna
TWI797095B (zh) 2016-10-24 2023-04-01 美商格瑞爾有限責任公司 腫瘤檢測之方法及系統
US11435339B2 (en) 2016-11-30 2022-09-06 The Chinese University Of Hong Kong Analysis of cell-free DNA in urine
EP3555311B1 (en) * 2016-12-13 2024-06-26 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
US20200255896A1 (en) * 2017-01-11 2020-08-13 Quest Diagnostics Investments Llc Method for non-invasive prenatal screening for aneuploidy
EP3575407B1 (en) * 2017-01-24 2024-03-27 BGI Genomics Co., Ltd. Method for determining proportion of cell-free nucleic acids from predetermined source in biological sample
ES2990117T3 (es) 2017-01-25 2024-11-28 Univ Hong Kong Chinese Aplicaciones de diagnóstico que utilizan fragmentos de ácido nucleico
CN107247873B (zh) * 2017-03-29 2020-04-14 电子科技大学 一种差异甲基化位点识别方法
CN111417731A (zh) * 2017-05-12 2020-07-14 哈佛学院校长同事会 通用早期癌症诊断
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
WO2019010564A1 (en) 2017-07-12 2019-01-17 University Health Network DETECTION AND CLASSIFICATION OF CANCER USING METHYLOME ANALYSIS
JP7434143B2 (ja) * 2017-07-12 2024-02-20 アンディ・コーポレイション パターン認識システム
ES2959360T3 (es) * 2017-07-26 2024-02-23 Univ Hong Kong Chinese Mejora del cribado del cáncer mediante ácidos nucleicos víricos acelulares
WO2019055819A1 (en) 2017-09-14 2019-03-21 Grail, Inc. METHODS FOR PREPARING A SEQUENCING LIBRARY FROM SINGLE STRANDED DNA
WO2019067973A1 (en) 2017-09-28 2019-04-04 Grail, Inc. ENRICHMENT OF SHORT NUCLEIC ACID FRAGMENTS IN THE PREPARATION OF SEQUENCING LIBRARIES
US11168356B2 (en) 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
CA3092998A1 (en) 2018-03-13 2019-09-19 Grail, Inc. Anomalous fragment detection and classification
WO2019178496A1 (en) * 2018-03-15 2019-09-19 Grail, Inc. Tissue-specific methylation marker
EP3775198A4 (en) 2018-04-02 2022-01-05 Grail, Inc. METHYLATION MARKERS AND TARGETED METHYLATION PROBE PANELS
EP3776381A4 (en) * 2018-04-13 2022-01-05 Freenome Holdings, Inc. IMPLEMENTATION OF MACHINE LEARNING FOR MULTI-ANALYTE TESTS OF BIOLOGICAL SAMPLES
US20210104297A1 (en) * 2018-04-16 2021-04-08 Grail, Inc. Systems and methods for determining tumor fraction in cell-free nucleic acid
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (zh) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 一种基于perl语言的种群特异SNP位点的自动化分析方法
CN113286881A (zh) 2018-09-27 2021-08-20 格里尔公司 甲基化标记和标靶甲基化探针板
CN109295230A (zh) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法
WO2020106906A1 (en) 2018-11-21 2020-05-28 Avida Biomed, Inc. Methods for targeted nucleic acid library formation
AU2019410635A1 (en) * 2018-12-19 2021-06-17 Grail, Inc. Cell-free DNA end characteristics
WO2020132572A1 (en) 2018-12-21 2020-06-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
CA3127894A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
AU2020246747A1 (en) 2019-03-25 2021-08-26 Grail, Inc. Determining linear and circular forms of circulating nucleic acids
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
EP3963095A4 (en) * 2019-05-03 2023-01-25 Cornell University MARKERS FOR IDENTIFICATION AND QUANTIFICATION OF NUCLEIC ACID SEQUENCE MUTATIONS, EXPRESSION, SPLICE VARIANT, TRANSLOCATION, COPY NUMBER OR METHYLATION CHANGES
KR102452413B1 (ko) * 2019-08-19 2022-10-11 주식회사 지씨지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
WO2021034034A1 (ko) * 2019-08-19 2021-02-25 주식회사 녹십자지놈 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
AU2020391488A1 (en) * 2019-11-27 2022-06-09 GRAIL, Inc Systems and methods for evaluating longitudinal biological feature data
GB2612412B (en) 2020-01-31 2025-10-10 Agilent Technologies Inc Systems and methods for targeted nucleic acid capture
CN115398007A (zh) * 2020-02-10 2022-11-25 帕洛根公司 纳米孔装置和使用其检测和分类带电粒子的方法
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
CA3169488A1 (en) * 2020-02-28 2021-09-02 Collin MELTON Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (zh) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 一种检测11种癌症的探针组合物
RU2738675C1 (ru) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов
CN116848262A (zh) * 2020-11-19 2023-10-03 纽克莱克斯有限公司 使用限制性酶和高通量测序检测dna样品中的甲基化改变
AU2021401813A1 (en) * 2020-12-17 2023-07-06 Dana-Farber Cancer Institute, Inc. Methods of cancer detection using extraembryonically methylated cpg islands
CN112813148A (zh) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 飞行时间质谱检测5-羟甲基胞嘧啶的方法
WO2023052917A1 (en) * 2021-09-28 2023-04-06 Act Genomics (ip) Limited Methylation biomarker selection apparatuses and methods
KR20230059423A (ko) 2021-10-26 2023-05-03 주식회사 지씨지놈 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법
TW202321464A (zh) * 2021-11-04 2023-06-01 西班牙商通用診斷股份公司 製備用於基因定序之生物樣本的系統與方法
EP4530356A3 (en) 2022-02-07 2025-07-09 Centre for Novostics Fragmentation for measuring methylation and disease
US20240150840A1 (en) * 2022-02-22 2024-05-09 Flagship Pioneering Innovations Vi, Llc Intra-individual analysis for presence of health conditions
CN115064211B (zh) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 一种基于全基因组甲基化测序的ctDNA预测方法及装置
CN115612723B (zh) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 植入前胚胎的筛选方法
WO2024203348A1 (ja) * 2023-03-31 2024-10-03 ソニーグループ株式会社 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法
CN118737268A (zh) * 2023-05-04 2024-10-01 杭州圣庭医疗科技有限公司 一种鉴定肿瘤组织来源的试剂盒的数据分析方法
CN117025753A (zh) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 检测染色体变异的方法和装置
CN117079822B (zh) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） 一种妊娠早中期四因子预测胎儿脑损伤的系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007132166A2 (en) 2006-05-03 2007-11-22 The Chinese University Of Hong Kong New fetal methylation markers
WO2011141711A1 (en) 2010-05-12 2011-11-17 Aberystwyth University Methods for selecting methylation markers

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) * 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
EP1342794B1 (en) 2002-03-05 2005-12-14 Epigenomics AG Method and device for determination of tissue specificity of free floating DNA in bodily fluids
EP1570081A4 (en) * 2002-11-19 2006-05-31 Amgen Inc AMPLIFIED GENES INVOLVED IN CANCER
US20060183128A1 (en) 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
CA2902980A1 (en) * 2004-03-08 2005-09-29 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
AU2006251937A1 (en) 2005-05-27 2006-11-30 John Wayne Cancer Institute Use of free circulating DNA for diagnosis, prognosis, and treatment of cancer
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
TWI335354B (en) * 2006-09-27 2011-01-01 Univ Hong Kong Chinese Methods for the detection of the degree of the methylation of a target dna and kits
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
CN106886688B (zh) 2007-07-23 2020-07-10 香港中文大学 用于分析癌症相关的遗传变异的系统
JP4347372B2 (ja) 2007-08-10 2009-10-21 トヨタ自動車株式会社 静電塗装装置
US20110028333A1 (en) 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
US20120208711A1 (en) 2009-10-02 2012-08-16 Centre For Addiction And Mental Health Method for Analysis of DNA Methylation Profiles of Cell-Free Circulating DNA in Bodily Fluids
WO2011057094A1 (en) * 2009-11-05 2011-05-12 The Chinese University Of Hong Kong Fetal genomic analysis from a maternal biological sample
AU2010317019B2 (en) 2009-11-06 2014-10-30 The Chinese University Of Hong Kong Size-based genomic analysis
US10662474B2 (en) * 2010-01-19 2020-05-26 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing
PL2529032T3 (pl) * 2010-01-26 2017-07-31 Nipd Genetics Ltd Sposoby i kompozycje do nieinwazyjnego prenatalnego diagnozowania aneuploidii płodu
KR101903547B1 (ko) 2010-04-29 2018-10-04 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 게놈 모델에 대한 데이터 통합을 이용하는 경로 인지 알고리즘 （ｐａｒａｄｉｇｍ）
WO2011150075A2 (en) 2010-05-25 2011-12-01 The Johns Hopkins University Compositions and methods for detecting a neoplasia
CA2802111A1 (en) * 2010-07-23 2012-01-26 Esoterix Genetic Laboratories, Llc Identification of differentially represented fetal or maternal genomic regions and uses thereof
BR112013001754A2 (pt) * 2010-07-23 2016-05-31 Harvard College método para detectar marcas de doença ou condições em fluídos corpóreos
WO2012031329A1 (en) 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
EP4269623A3 (en) 2010-11-30 2024-03-06 The Chinese University Of Hong Kong Analysis of a biological sample of an organism for chromosomal deletions or amplifications associated with cancer
WO2014043763A1 (en) * 2012-09-20 2014-03-27 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007132166A2 (en) 2006-05-03 2007-11-22 The Chinese University Of Hong Kong New fetal methylation markers
WO2011141711A1 (en) 2010-05-12 2011-11-17 Aberystwyth University Methods for selecting methylation markers

Also Published As

Publication number Publication date
KR20200085928A (ko) 2020-07-15
TW202043483A (zh) 2020-12-01
KR20220065034A (ko) 2022-05-19
HUE053822T2 (hu) 2021-07-28
LT3354747T (lt) 2021-04-12
TWI707953B (zh) 2020-10-21
PT3536807T (pt) 2024-02-01
TWI806621B (zh) 2023-06-21
NZ706269A (en) 2016-08-26
JP7594817B2 (ja) 2024-12-05
IL237495B (en) 2019-09-26
TW201418474A (zh) 2014-05-16
PL3354747T3 (pl) 2021-07-26
EP4335929A3 (en) 2024-05-29
AU2017251832A1 (en) 2017-11-16
ZA201501772B (en) 2016-10-26
CN117757932A (zh) 2024-03-26
AU2013317708A1 (en) 2015-04-09
ES2969567T3 (es) 2024-05-21
CY1124139T1 (el) 2022-05-27
HK1206797A1 (en) 2016-01-15
FI3536807T3 (fi) 2024-02-01
IL299444A (en) 2023-02-01
JP2025026936A (ja) 2025-02-26
ES2862726T3 (es) 2021-10-07
HK1257868A1 (en) 2019-11-01
PH12015500547A1 (en) 2015-05-04
WO2014043763A1 (en) 2014-03-27
DK4056712T3 (da) 2024-08-26
HK1207124A1 (en) 2016-01-22
TW202334438A (zh) 2023-09-01
EP2898100B2 (en) 2023-05-10
JP6683752B2 (ja) 2020-04-22
AU2017251832B2 (en) 2019-10-10
IL237495A0 (en) 2015-04-30
AU2013317708C1 (en) 2017-11-23
JP2015536639A (ja) 2015-12-24
PL2898100T3 (pl) 2018-06-29
EP3354747B1 (en) 2021-02-17
JP2018121644A (ja) 2018-08-09
HRP20240210T1 (hr) 2024-05-10
TWI784258B (zh) 2022-11-21
BR112015006183A2 (pt) 2017-07-04
PH12022552061A1 (en) 2024-03-11
PT3354747T (pt) 2021-05-07
MY187444A (en) 2021-09-22
SG10201705198UA (en) 2017-07-28
EP3354747A1 (en) 2018-08-01
CA3122779A1 (en) 2014-03-27
ES2994426T3 (en) 2025-01-23
DK3536807T3 (da) 2024-02-05
FI4056712T3 (fi) 2024-08-29
IL268512B2 (en) 2023-06-01
EP3536807B1 (en) 2023-11-29
EP2898100B1 (en) 2017-11-22
KR20210120124A (ko) 2021-10-06
HRP20241142T1 (hr) 2024-11-22
NZ717423A (en) 2017-08-25
CA2884066C (en) 2021-08-10
ES2665273T3 (es) 2018-04-25
EP3536807A1 (en) 2019-09-11
IL299444B1 (en) 2024-07-01
AU2020200128A1 (en) 2020-01-30
AU2013317708B2 (en) 2017-08-03
TW202305145A (zh) 2023-02-01
AU2025205087A1 (en) 2025-07-24
CA2884066A1 (en) 2014-03-27
JP6985753B2 (ja) 2021-12-22
MY173356A (en) 2020-01-21
MX360034B (es) 2018-10-19
SG11201501927VA (en) 2015-04-29
TW201907013A (zh) 2019-02-16
SMT202100256T1 (it) 2021-05-07
KR102587176B1 (ko) 2023-10-06
PL4056712T3 (pl) 2024-12-02
IL268512A (en) 2019-09-26
CN104781422A (zh) 2015-07-15
EP2898100A4 (en) 2016-05-11
CN104781422B (zh) 2023-12-26
MX2015003571A (es) 2015-06-22
IL299444B2 (en) 2024-11-01
EP2898100B9 (en) 2023-08-02
AU2022201026B2 (en) 2025-04-03
TWI640634B (zh) 2018-11-11
EP4056712A1 (en) 2022-09-14
ES2665273T5 (es) 2023-10-02
KR20150082228A (ko) 2015-07-15
HRP20210716T1 (hr) 2021-06-11
HUE068129T2 (hu) 2024-12-28
EP4335929A2 (en) 2024-03-13
EP4056712B1 (en) 2024-07-31
PL3536807T3 (pl) 2024-05-06
JP2020108400A (ja) 2020-07-16
IL313451A (en) 2024-08-01
JP2022031753A (ja) 2022-02-22
BR122021021825B1 (pt) 2022-05-24
DK2898100T4 (da) 2023-07-24
JP2024009833A (ja) 2024-01-23
DK3354747T3 (da) 2021-04-19
AU2020200128B2 (en) 2021-11-18
LT4056712T (lt) 2024-09-10
HUE066054T2 (hu) 2024-07-28
SI4056712T1 (sl) 2024-10-30
KR102390711B1 (ko) 2022-04-26
PT4056712T (pt) 2024-08-08
KR102148547B1 (ko) 2020-08-26
EA201500327A1 (ru) 2015-07-30
PT2898100T (pt) 2018-02-26
PL2898100T5 (pl) 2023-11-06
EP2898100A1 (en) 2015-07-29
KR20230145530A (ko) 2023-10-17
JP6317354B2 (ja) 2018-04-25
AU2022201026A1 (en) 2022-03-10
DK2898100T3 (en) 2018-02-26
BR122021021823B1 (pt) 2023-04-25
BR112015006183B1 (pt) 2022-04-26
PH12015500547B1 (en) 2024-05-17
EP3839065A1 (en) 2021-06-23

Similar Documents

Publication Publication Date Title
JP7594817B2 (ja) 血漿による胎児または腫瘍のメチロームの非侵襲的決定
US20250349386A1 (en) Non-invasive detection of tissue abnormality using methylation
TWI901957B (zh) 來自血漿之胚胎或腫瘤甲基化模式組(methylome)之非侵入性測定
HK40013800B (en) Non-invasive determination of methylome of tumor from plasma
HK1207124B (zh) 从血浆无创测定胎儿或肿瘤的甲基化组
HK1206797B (en) Non-invasive determination of methylome of fetus or tumor from plasma

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20200706

Application number text: 1020157010184

Filing date: 20150420

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200724

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20201012

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20210625

PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20210923

Application number text: 1020157010184

Filing date: 20150420

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210924

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210924

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240823

Start annual number: 4

End annual number: 4